Dashboard
Manage Tickers

EVAX Evaxion Biotech A/S

Nasdaq evaxion-biotech.com


$ 7.11 $ 0.30 (4.42 %)    

Monday, 20-Oct-2025 17:18:39 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.11 $ 7.61 (1.26 %)
DIA $ 467.12 $ 5.24 (1.13 %)
SPY $ 671.75 $ 6.91 (1.04 %)
TLT $ 91.68 $ 0.35 (0.38 %)
GLD $ 401.36 $ 14.16 (3.64 %)
$ 7.09
$ 7.00
$ 6.98 x 1
$ 7.12 x 99
$ 6.95 - $ 8.10
$ 1.20 - $ 15.50
582,728
na
497.23M
$ 4.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

lake-street-maintains-buy-on-evaxion-raises-price-target-to-11
Lake Street Maintains Buy on Evaxion, Rais...
10/20/2025 13:16:06

Lake Street analyst Thomas Flaten maintains Evaxion (NASDAQ:EVAX) with a Buy and raises the price target from $6 to $11.

hc-wainwright--co-reiterates-buy-on-evaxion-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Evax...
10/20/2025 12:01:59

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion (NASDAQ:EVAX) with a Buy and maintains $16 price t...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
10/17/2025 21:07:13

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/17/2025 17:05:58

evaxion-as-reports-two-year-phase-2-data-showing-results-for-its-personalized-cancer-vaccine-evx-01-in-advanced-melanoma-study-showed-a-75-objective-response-rate-with-4-of-16-patients-achieving-complete-responses-and-92-maintaining-durable-responses-at-24-months-with-no-relapses
Evaxion A/S Reports Two-Year Phase 2 Data ...
10/17/2025 12:21:34

Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ power...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/15/2025 17:07:00

evaxion-will-present-comprehensive-phase-2-trial-data-for-its-lead-cancer-vaccine-evx-01-at-the-esmo-congress-2025-in-berlin-oct-1721-2025
Evaxion Will Present Comprehensive Phase 2...
10/13/2025 12:09:35

Presentation will cover two-year clinical efficacy, immunogenicity and safety dataData will be presented at an oral session on ...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 17:06:17

evaxion-to-present-new-biomarker-and-immune-data-from-ongoing-phase-2-trial-with-evx-01-at-sitc-2025-annual-meeting
Evaxion To Present New Biomarker And Immun...
10/03/2025 13:02:29

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
09/26/2025 21:06:04

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/25/2025 17:06:09

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

hc-wainwright--co-maintains-buy-on-evaxion-raises-price-target-to-16
HC Wainwright & Co. Maintains Buy on Evaxi...
09/25/2025 15:43:58

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Evaxion (NASDAQ: EVAX) with a Buy and raises the price targ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/25/2025 12:08:49

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their ...

Core News & Articles
Market-Moving News for September 25th
09/25/2025 11:24:32

OPEN: 11% | Opendoor shares are trading higher after Jane Street Group disclosed in a 13G filing that it holds a 5.9% stake in ...

evaxion-out-licenses-vaccine-candidate-evx-b3-to-msd-co-will-receive-75m-cash-payment-and-up-to-592m-in-milestones-as-well-as-royalties-on-sales
Evaxion Out-Licenses Vaccine Candidate EVX...
09/25/2025 11:05:10

evaxion-says-current-cash-at-hand-of-147m-sufficient-to-fund-our-operating-expenses-and-capital-expenditure-requirements-until-mid-2026
Evaxion Says Current Cash At Hand Of $14.7...
08/14/2025 11:33:33

evaxion-biotech-q2-eps-002-may-not-be-comparable-to-066-estimate-sales-37000k-down-from-154000k-yoy
Evaxion Biotech Q2 EPS $(0.02) May Not Be ...
08/14/2025 11:32:20

Core News & Articles
Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

insights-ahead-evaxion-biotechs-quarterly-earnings
Insights Ahead: Evaxion Biotech's Quarterl...
08/13/2025 18:02:22

evaxion-presents-two-year-clinical-efficacy-data-from-phase-2-trial-with-ai-designed-personalized-cancer-vaccine-evx-01-at-esmo-congress-2025
Evaxion Presents Two-Year Clinical Efficac...
07/25/2025 13:04:49

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION